Gene Therapy for APOE4 Homozygote of Alzheimer's Disease

Clinical trial NCT03634007 · COMPLETED

Trial details

NCT number: NCT03634007
Sponsor: Lexeo Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Early Onset Alzheimer Disease

Start date: 2019-11-06
Primary completion: 2024-11-07
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.